Gunnar Telhammar
Financieel Directeur/CFO bij XINTELA AB
Actieve functies van Gunnar Telhammar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| XINTELA AB | Financieel Directeur/CFO | 01-01-2013 | - |
| ACOUSORT AB | Financieel Directeur/CFO | 01-01-2016 | - |
| LIFEASSAYS AB (PUBL) | Financieel Directeur/CFO | - | - |
| TENDO AB | Financieel Directeur/CFO | - | - |
| SENSODETECT AKTIEBOLAG | Financieel Directeur/CFO | - | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Financieel Directeur/CFO | - | - |
| BioFinans AB | Directeur/Bestuurslid | 01-01-2004 | - |
| Algemeen Directeur | 01-01-2004 | - | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Financieel Directeur/CFO | 01-01-2019 | - |
| Directeur/Bestuurslid | 01-01-2019 | - |
Loopbaan van Gunnar Telhammar
Eerdere bekende functies van Gunnar Telhammar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Telepartner AS (Norway) | Financieel Directeur/CFO | 01-01-1990 | 01-01-1996 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Gunnar Telhammar
| University of Lund | Graduate Degree |
Statistieken
Internationaal
| Zweden | 14 |
| Noorwegen | 2 |
Operationeel
| Director of Finance/CFO | 11 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectoraal
| Health Technology | 9 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 7 |
|---|---|
| XINTELA AB | Health Technology |
| BIBBINSTRUMENTS AB | Health Technology |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| AEGIRBIO AB | Health Technology |
| ACOUSORT AB | Distribution Services |
| TENDO AB | Health Technology |
| SENSODETECT AKTIEBOLAG | Commercial Services |
| Bedrijven in privébezit | 6 |
|---|---|
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Health Technology |
| BioFinans AB | |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Health Technology |
LifeAssays AB
 LifeAssays AB Medical SpecialtiesHealth Technology LifeAssays AB is a diagnostic company, which engages in the provision of point-of-care diagnostic testing for veterinarians, community health centers and primary physicians. It's products include own produced instruments and disposable agents as well as blood analysis systems LifeAssays Reader and LifeAssays VetReader. The company was founded on August 17, 2000 and is headquartered in Lund, Sweden. | Health Technology |
| Telepartner AS (Norway) | |
| Preelumina Diagnostics AB |
- Beurs
- Insiders
- Gunnar Telhammar
- Ervaring
